UPSTREAM BIO INC (UPB) Stock Analyst Ratings
USA - NASDAQ:UPB - US91678A1079 - Common Stock
25.77 USD
+1.58 (+6.53%)
25.55 USD
-0.22 (-0.85%)
ChartMill assigns a Buy % Consensus number of 83% to UPB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 76.5. This target is 196.86% above the current price.
UPB was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about UPB.
In the previous month the buy percentage consensus was at a similar level.
UPB was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-14 | Truist Securities | Initiate | Buy |
| 2024-11-05 | TD Cowen | Initiate | Buy |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
UPSTREAM BIO INC / UPB FAQ
What is the price target for UPB stock?
8 analysts have analysed UPB and the average price target is 76.5 USD. This implies a price increase of 196.86% is expected in the next year compared to the current price of 25.77.
How do analysts rate UPSTREAM BIO INC (UPB)?
The consensus rating for UPSTREAM BIO INC (UPB) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for UPB stock?
The number of analysts covering UPSTREAM BIO INC (UPB) is 8.